// company-profile
Olema Pharmaceuticals, Inc.
OLMAExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings112Insiders35
// api This Olema Pharmaceuticals, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.
// activity-summary
No insider transactions in the last 30 days.
// 90-day insight
Over the last 90 days, Olema Pharmaceuticals, Inc. insiders bought $0 across 2 transactions with no open-market sales.
- Most active insider: Raman Prakash with 2 transactions totaling $0.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Olema Pharmaceuticals, Inc. as of 2026-03-31
Total reported AUM
$1.51B
QoQ change
-29.2%
Reporting period
2026-03-31
#1
FMR LLC
CIK 315066
$119.6M
8.0M shares
#2
Paradigm Biocapital Advisors LP
CIK 1855655
$119.6M
8.0M shares
#3
Bain Capital Life Sciences Investors, LLC
CIK 1703031
$111.4M
7.5M shares
Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 28, 2026 | Raman Prakash | OLMA | Award | 24,150 | $0.00 | $0K |
| Apr 28, 2026 | Raman Prakash | OLMA | Award | 2,911 | $0.00 | $0K |
| Mar 4, 2026 | Mitchell Shawnte | OLMA | Option Exercise | 25,000 | $0.00 | $0K |
| Mar 4, 2026 | Mitchell Shawnte | OLMA | Option Exercise | 25,000 | $4.37 | $109K |
| Mar 4, 2026 | Mitchell Shawnte | OLMA | Sale | 233 | $24.69 | $6K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Popular companies on Form4API
Browse insider trading activity for other actively-filed companies.